Logotype for Lexeo Therapeutics Inc

Lexeo Therapeutics (LXEO) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Lexeo Therapeutics Inc

Proxy filing summary

30 Apr, 2026

Voting matters and shareholder proposals

  • Election of Paula HJ Cholmondeley, Brenda Cooperstone, and R. Nolan Townsend as Class III directors is proposed, with board recommendation to vote in favor.

  • Ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, is recommended.

  • Proxyholders are authorized to vote on any other business that may properly come before the meeting or any adjournment.

Board of directors and corporate governance

  • Three nominees are presented for election as Class III directors, indicating a staggered board structure.

Audit committee and external auditor matters

  • KPMG LLP is proposed for ratification as the independent auditor for the next fiscal year.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more